psalexa
logo

Sleeping Aids Market

Global Sleeping Aids Market Size, Share, Development, Growth and Demand Forecast to 2022 – Industry Insights by Sleep Disorder (Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Sleep Walking and Others), by Products (Medication, Sleep Laboratories, Mattresses and Pillows, Sleep Apnea Devices and Others)

Published: June 2016
Report Code: LS10015
Available Format:
Pages: 132
Category : Healthcare

Chapter 1. Research Scope & Methodology

1.1 Market Definition

1.2 Market Scope

1.2.1 Global sleeping aids market breakdown by sleep disorder

1.2.2 Global sleeping aids market breakdown by product

1.2.3 Market breakdown by geography

1.3 Research Methodology and Sources

Chapter 2. Executive Summary

2.1 Key Findings

2.2 Research Summary

Chapter 3. Market Outlook

3.1 Introduction

3.2 Trends in the Market

3.2.1 Increasing demand for wearable monitors and sensors

3.2.2 Increasing demand for home sleep test

3.2.3 Increased usage of CPAP

3.3 Factors Driving Growth of the Market and its Impact on Market Forecast

3.3.1 Increasing geriatric population

3.3.2 Increased demand for sleeping pills attributed to stressful modern lifestyle

3.3.3 Sleep disorder awareness initiatives by various organizations

3.3.4 Impact analysis of drivers on market forecast

3.4 Factors Hindering Growth of the Market and its Impact on Market Forecast

3.4.1 Patent expiration of sleep disorder treatment pills

3.4.2 Side effects associated with sleeping aids medications

3.4.3 Impact analysis of restraints on market forecast

Chapter 4. Sales/Distribution Channel Analysis

Chapter 5. Global Sleeping Aids Market Size and Forecast (2012 – 2022)

5.1 Global Sleeping Aids Market, by Sleep Disorder

5.2 Global Sleeping Aids Market, by Product

5.3 Global Sleeping Aids Market, by Region

Chapter 6. Global Sleeping Aids Market, by Sleep Disorder

6.1 Sleep Apnea Market

6.2 Insomnia Market

6.3 Sleep Walking Market

6.4 Restless Legs Syndrome Market

6.5 Narcolepsy Market

Chapter 7. Global Sleeping Aids Market, by Product

7.1 Sleep Medication Market

7.2 Sleep Apnea Device Market

7.3 Mattress & Pillow Market

7.4 Sleep Laboratory Market

Chapter 8. Global Sleep Medication Market, by Type

8.1 Prescription-Based Sleep Medication Market

8.2 Over-the-Counter (OTC) Sleep Medication Market

8.3 Herbal Sleep Medication Market

Chapter 9. Global Sleeping Aids Market, by Geography

9.1 North America Sleeping Aids Market

9.1.1 North America sleeping aids market, by sleep disorder

9.1.2 North America sleeping aids market, by product

9.1.2.1 North America sleep medication market, by type

9.1.3 North America sleeping aids market, by country

9.1.3.1 U.S. sleeping aids market

9.1.3.1.1 U.S. sleeping aids market, by sleep disorder

9.1.3.1.2 U.S. sleeping aids market, by product

9.1.3.1.3 U.S. sleep medication market, by type

9.2 Europe Sleeping Aids Market

9.2.1 Europe sleeping aids market, by sleep disorder

9.2.2 Europe sleeping aids market, by product

9.2.2.1 Europe sleep medication market, by type

9.2.3 Europe sleeping aids market, by country

9.3 Asia Sleeping Aids Market

9.3.1 Asia sleeping aids market, by sleep disorder

9.3.2 Asia sleeping aids market, by product

9.3.2.1 Asia sleep medication market, by type

9.3.3 Asia sleeping aids market, by country

9.4 Rest of the World (RoW) Sleeping Aids Market

9.4.1 RoW sleeping aids market, by sleep disorder

9.4.2 RoW sleeping aids market, by product

9.4.2.1 RoW sleep medication market, by type

9.4.3 RoW sleeping aids market, by country

Chapter 10. Competitive Positioning and Market Share Analysis

10.1 Porter's Five Forces of Competitive Position Analysis

10.1.1 Bargaining power of buyers

10.1.2 Bargaining power of suppliers

10.1.3 Threat of new entrants

10.1.4 Intensity of rivalry

10.1.5 Threat of substitutes

10.2 Market Share Analysis of Major Players

10.2.1 Market share analysis of major players in global medication market

10.2.2 Market share analysis of major players in global sleep apnea devices market

10.2.3 Market share analysis of major players in global mattresses market

Chapter 11. Company Profiles and Strategic Developments

11.1 Key Company Profiles

11.1.1 Merck & Co. Inc.

11.1.1.1 Business overview

11.1.1.2 Products and services

11.1.2 Sanofi

11.1.2.1 Business Overview

11.1.2.2 Products and services

11.1.3 Koninklijke Philips N.V.

11.1.3.1 Business overview

11.1.3.2 Products and services

11.1.4 Pfizer Inc.

11.1.4.1 Business overview

11.1.4.2 Products and services

11.1.5 GlaxoSmithKline PLC

11.1.5.1 Business overview

11.1.5.2 Products and services

11.1.6 SleepMed Inc.

11.1.6.1 Business overview

11.1.6.2 Products and services

11.1.7 Cadwell Laboratories Inc.

11.1.7.1 Business overview

11.1.7.2 Products and services

11.1.8 Natus Medical Incorporated

11.1.8.1 Business overview

11.1.8.2 Products and services

11.1.9 Drive Medical Ltd.

11.1.9.1 Business overview

11.1.9.2 Products and services

11.1.10 Takeda Pharmaceutical Company Limited

11.1.10.1 Business overview

11.1.10.2 Products and services

11.1.11 Compumedics Limited

11.1.11.1 Business overview

11.1.11.2 Products and services

11.1.12 Becton, Dickinson and Compan

11.1.12.1 Business overview

11.1.12.2 Product and service offerings

11.1.13 Teva Pharmaceutical Industries Ltd.

11.1.13.1 Business overview

11.1.13.2 Products and services

11.2 Strategic Developments in the Global Sleeping Aids Market

11.2.1 Merger & acquisition

11.2.2 Partnership/ collaboration

11.2.3 Product launch

11.2.4 Others

Chapter 12. Appendix

12.1 List of Abbreviations

LIST OF TABLES

TABLE 1 SPECIFIC PRIMARY AND SECONDARY SOURCES USED FOR THIS PUBLICATION

TABLE 2 GLOBAL SLEEPING AIDS MARKET SNAPSHOT

TABLE 3 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 SLEEPING AIDS DRUGS AND THEIR SIDE EFFECTS

TABLE 5 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 6 GLOBAL SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2012 – 2015)

TABLE 7 GLOBAL SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2016 – 2022)

TABLE 8 GLOBAL SLEEPING AIDS MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 9 GLOBAL SLEEPING AIDS MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 10 GLOBAL SLEEPING AIDS MARKET, BY REGION, $M (2012 – 2015)

TABLE 11 GLOBAL SLEEPING AIDS MARKET, BY REGION, $M (2016 – 2022)

TABLE 12 GLOBAL SLEEP APNEA MARKET, BY REGION, $M (2012 – 2015)

TABLE 13 GLOBAL SLEEP APNEA MARKET, BY REGION, $M (2016 – 2022)

TABLE 14 GLOBAL INSOMNIA MARKET, BY REGION, $M (2012 – 2015)

TABLE 15 GLOBAL INSOMNIA MARKET, BY REGION, $M (2016 – 2022)

TABLE 16 GLOBAL SLEEP WALKING MARKET, BY REGION, $M (2012 – 2015)

TABLE 17 GLOBAL SLEEP WALKING MARKET, BY REGION, $M (2016 – 2022)

TABLE 18 GLOBAL RESTLESS LEGS SYNDROME MARKET, BY REGION, $M (2012 – 2015)

TABLE 19 GLOBAL RESTLESS LEGS SYNDROME MARKET, BY REGION, $M (2016 – 2022)

TABLE 20 GLOBAL NARCOLEPSY MARKET, BY REGION, $M (2012 – 2015)

TABLE 21 GLOBAL NARCOLEPSY MARKET, BY REGION, $M (2016 – 2022)

TABLE 22 GLOBAL SLEEP MEDICATION MARKET, BY REGION, $M (2012 – 2015)

TABLE 23 GLOBAL SLEEP MEDICATION MARKET, BY REGION, $M (2016 – 2022)

TABLE 24 GLOBAL SLEEP APNEA DEVICE MARKET, BY REGION, $M (2012 – 2015)

TABLE 25 GLOBAL SLEEP APNEA DEVICE MARKET, BY REGION, $M (2016 – 2022)

TABLE 26 GLOBAL MATTRESS & PILLOW MARKET, BY REGION, $M (2012 – 2015)

TABLE 27 GLOBAL MATTRESS & PILLOW MARKET, BY REGION, $M (2016 – 2022)

TABLE 28 GLOBAL SLEEP LABORATORY MARKET, BY REGION, $M (2012 – 2015)

TABLE 29 GLOBAL SLEEP LABORATORY MARKET, BY REGION, $M (2016 – 2022)

TABLE 30 GLOBAL PRESCRIPTION-BASED SLEEP MEDICATION MARKET, BY REGION, $M  (2012 – 2015)

TABLE 31 GLOBAL PRESCRIPTION-BASED SLEEP MEDICATION MARKET, BY REGION, $M  (2016 – 2022)

TABLE 32 GLOBAL OTC SLEEP MEDICATION MARKET, BY REGION, $M (2012 – 2015)

TABLE 33 GLOBAL OTC SLEEP MEDICATION MARKET, BY REGION, $M (2016 – 2022)

TABLE 34 GLOBAL HERBAL SLEEP MEDICATION MARKET, BY REGION, $M (2012 – 2015)

TABLE 35 GLOBAL HERBAL SLEEP MEDICATION MARKET, BY REGION, $M (2016 – 2022)

TABLE 36 SPECIFIC SLEEPING SPECIALIST AND INSTITUTES IN NORTH AMERICA

TABLE 37 NORTH AMERICA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2012 – 2015)

TABLE 38 NORTH AMERICA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2016 – 2022)

TABLE 39 NORTH AMERICA SLEEPING AIDS MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 40 NORTH AMERICA SLEEPING AIDS MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 41 NORTH AMERICA SLEEP MEDICATION MARKET, BY TYPE, $M (2012 – 2015)

TABLE 42 NORTH AMERICA SLEEP MEDICATION MARKET, BY TYPE, $M (2016 – 2022)

TABLE 43 NORTH AMERICA SLEEPING AIDS MARKET, BY COUNTRY, $M (2012 – 2015)

TABLE 44 NORTH AMERICA SLEEPING AIDS MARKET, BY COUNTRY, $M (2016 – 2022)

TABLE 45 U.S. SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2012 – 2015)

TABLE 46 U.S. SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2016 – 2022)

TABLE 47 U.S. SLEEPING AIDS MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 48 U.S. SLEEPING AIDS MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 49 U.S. SLEEP MEDICATION MARKET, BY TYPE, $M (2012 – 2015)

 TABLE 50 U.S. SLEEP MEDICATION MARKET, BY TYPE, $M (2016 – 2022)

TABLE 51 SPECIFIC SLEEPING SPECIALIST AND INSTITUTES IN EUROPE

TABLE 52 EUROPE SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2012 – 2015)

TABLE 53 EUROPE SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2016 – 2022)

TABLE 54 EUROPE SLEEPING AIDS MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 55 EUROPE SLEEPING AIDS MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 56 EUROPE SLEEP MEDICATION MARKET, BY TYPE, $M (2012 – 2015)

TABLE 57 EUROPE SLEEP MEDICATION MARKET, BY TYPE, $M (2016 – 2022)

TABLE 58 EUROPE SLEEPING AIDS MARKET, BY COUNTRY, $M (2012 – 2015)

TABLE 59 EUROPE SLEEPING AIDS MARKET, BY COUNTRY, $M (2016 – 2022)

TABLE 60 SPECIFIC SLEEPING SPECIALIST AND INSTITUTES IN ASIA

TABLE 61 ASIA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2012 – 2015)

TABLE 62 ASIA SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2016 – 2022)

TABLE 63 ASIA SLEEPING AIDS MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 64 ASIA SLEEPING AIDS MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 65 ASIA SLEEP MEDICATION MARKET, BY TYPE, $M (2012 – 2015)

TABLE 66 ASIA SLEEP MEDICATION MARKET, BY TYPE, $M (2016 – 2022)

TABLE 67 ASIA SLEEPING AIDS MARKET, BY COUNTRY, $M (2012 – 2015)

TABLE 68 ASIA SLEEPING AIDS MARKET, BY COUNTRY, $M (2016 – 2022)

TABLE 69 SPECIFIC SLEEPING SPECIALIST AND INSTITUTES IN ROW

TABLE 70 ROW SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2012 – 2015)

TABLE 71 ROW SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2016 – 2022)

TABLE 72 ROW SLEEPING AIDS MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 73 ROW SLEEPING AIDS MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 74 ROW SLEEP MEDICATION MARKET, BY TYPE, $M (2012 – 2015)

TABLE 75 ROW SLEEP MEDICATION MARKET, BY TYPE, $M (2016 – 2022)

TABLE 76 ROW SLEEPING AIDS MARKET, BY COUNTRY, $M (2012 – 2015)

TABLE 77 ROW SLEEPING AIDS MARKET, BY COUNTRY, $M (2016 – 2022)

TABLE 78 MERCK & CO., INC. – KEY FACTS

TABLE 79 SANOFI – KEY FACTS

TABLE 80 KONINKLIJKE PHILIPS N.V. – KEY FACTS

TABLE 81 PFIZER, INC.– KEY FACTS

TABLE 82 GLAXOSMITHKLINE PLC – KEY FACTS

TABLE 83 SLEEPMED INC. – KEY FACTS

TABLE 84 CADWELL LABORATORIES, INC. – KEY FACTS

TABLE 85 NATUS MEDICAL INCORPORATED – KEY FACTS

TABLE 86 DRIVE MEDICAL LTD. – KEY FACTS

TABLE 87 TAKEDA PHARMACEUTICAL COMPANY LIMITED – KEY FACTS

TABLE 88 COMPUMEDICS LIMITED – KEY FACTS

TABLE 89 BECTON, DICKINSON AND COMPANY – KEY FACTS

TABLE 90 TEVA PHARMACEUTICAL INDUSTRIES LTD. – KEY FACTS

 

LIST OF FIGURES

FIG 1 RESEARCH SCOPE FOR THE GLOBAL SLEEPING AIDS MARKET

FIG 2 RESEARCH METHODOLOGY FOR GLOBAL SLEEPING AIDS MARKET

FIG 3 GERIATRIC POPULATION IN MAJOR COUNTRIES (2000-2050)

FIG 4 SALES/DISTRIBUTION CHANNEL – GLOBAL SLEEPING AIDS MARKET

FIG 5 SALES CHANNELS – ONLINE AND OFFLINE

FIG 6 CONSUMER PREFERNCE FOR DIFFERENT ONLINE CHANNELS

FIG 7 GLOBAL SLEEPING AIDS MARKET, $M (2012 – 2022)

FIG 8 GLOBAL SLEEPING AIDS MARKET, BY SLEEP DISORDER, $M (2012 – 2022)

FIG 9 GLOBAL SLEEPING AIDS MARKET SHARE, BY SLEEP DISORDER (2015)

FIG 10 GLOBAL SLEEPING AIDS MARKET, BY PRODUCT, $M (2012 – 2022)

FIG 11 GLOBAL SLEEPING AIDS MARKET SHARE, BY PRODUCT (2015)

FIG 12 GLOBAL SLEEPING AIDS MARKET, BY REGION, $M (2012 – 2022)

FIG 13 GLOBAL SLEEPING AIDS MARKET SHARE, BY REGION (2015)

FIG 14 TYPES OF SLEEPING DISORDER

FIG 15 GLOBAL SLEEP APNEA MARKET, BY REGION, $M (2012 – 2022)

FIG 16 GLOBAL INSOMNIA MARKET, BY REGION, $M (2012 – 2022)

FIG 17 GLOBAL SLEEP WALKING MARKET, BY REGION, $M (2012 – 2022)

FIG 18 GLOBAL RESTLESS LEGS SYNDROME MARKET, BY REGION, $M (2012 – 2022)

FIG 19 GLOBAL NARCOLEPSY MARKET, BY REGION, $M (2012 – 2022)

FIG 20 TYPES OF SLEEPING AIDS PRODUCTS

FIG 21 GLOBAL SLEEP MEDICATION MARKET, BY REGION, $M (2012 – 2022)

FIG 22 GLOBAL SLEEP APNEA DEVICE MARKET, BY REGION, $M (2012 – 2022)

FIG 23 GLOBAL MATTRESS & PILLOW MARKET, BY REGION, $M (2012 – 2022)

FIG 24 GLOBAL SLEEP LABORATORY MARKET, BY REGION, $M (2012 – 2022)

FIG 25 GLOBAL PRESCRIPTION-BASED SLEEP MEDICATION MARKET, BY REGION, $M (2012 – 2022)

FIG 26 GLOBAL OTC SLEEP MEDICATION MARKET, BY REGION, $M (2012 – 2022)

FIG 27 GLOBAL HERBAL SLEEP MEDICATION MARKET, BY REGION, $M (2012 – 2022)

FIG 28 SLEEPING AIDS MARKET IN MAJOR COUNTRIES

FIG 29 NORTH AMERICA SLEEPING AIDS MARKET SHARE, BY SLEEP DISORDER (2015)

FIG 30 NORTH AMERICA SLEEPING AIDS MARKET SHARE, BY PRODUCT (2015)

FIG 31 NORTH AMERICA SLEEP MEDICATION MARKET SHARE, BY TYPE (2015)

FIG 32 NORTH AMERICA SLEEPING AIDS MARKET SHARE, BY COUNTRY (2015)

FIG 33 U.S. SLEEPING AIDS MARKET SHARE, BY SLEEP DISORDER (2015)

FIG 34 U.S. SLEEPING AIDS MARKET SHARE, BY PRODUCT (2015)

FIG 35 U.S. SLEEP MEDICATION MARKET SHARE, BY TYPE (2015)

FIG 36 EUROPE SLEEPING AIDS MARKET SHARE, BY SLEEP DISORDER (2015)

FIG 37 EUROPE SLEEPING AIDS MARKET SHARE, BY PRODUCT (2015)

FIG 38 EUROPE SLEEP MEDICATION MARKET SHARE, BY TYPE (2015)

FIG 39 EUROPE SLEEPING AIDS MARKET SHARE, BY COUNTRY (2015)

FIG 40 ASIA SLEEPING AIDS MARKET SHARE, BY SLEEP DISORDER (2015)

FIG 41 ASIA SLEEPING AIDS MARKET SHARE, BY PRODUCT (2015)

FIG 42 ASIA SLEEP MEDICATION MARKET SHARE, BY TYPE (2015)

FIG 43 ASIA SLEEPING AIDS MARKET SHARE, BY COUNTRY (2015)

FIG 44 ROW SLEEPING AIDS MARKET SHARE, BY SLEEP DISORDER (2015)

FIG 45 ROW SLEEPING AIDS MARKET SHARE, BY PRODUCT (2015)

FIG 46 ROW SLEEP MEDICATION MARKET SHARE, BY TYPE (2015)

FIG 47 ROW SLEEPING AIDS MARKET SHARE, BY COUNTRY (2015)

FIG 48 PORTER’S FIVE FORCES OF COMPETITIVE POSITION ANALYSIS

FIG 49 MARKET SHARE OF MAJOR PLAYERS IN GLOBAL MEDICATION MARKET (2015)

FIG 50 MARKET SHARE OF MAJOR PLAYERS IN GLOBAL SLEEP APNEA DEVICES MARKET (2015)

FIG 51 MARKET SHARE OF MAJOR PLAYERS IN GLOBAL MATTRESSES MARKET (2015)

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5100
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry